Cite
Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment.
MLA
Chen, Xuxiang, et al. “Peptide Hormone ELABELA Promotes Rat Bone Marrow-Derived Mesenchymal Stem Cell Proliferation and Migration by Manipulating the Cell Cycle through the PI3K/AKT Pathway under the Hypoxia and Ischemia Microenvironment.” Stem Cell Research & Therapy, vol. 13, no. 1, Feb. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13287-021-02691-1.
APA
Chen, X., Zhou, C., Xu, D., Liu, X., Li, S., Hou, J., Zhang, K., Zeng, C., Zheng, G., Wu, H., Wu, H., Wang, W., Fu, J., & Wang, T. (2022). Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment. Stem Cell Research & Therapy, 13(1), 1–9. https://doi.org/10.1186/s13287-021-02691-1
Chicago
Chen, Xuxiang, Changqing Zhou, Daishi Xu, Xin Liu, Shuangmei Li, Jingyu Hou, Kanglong Zhang, et al. 2022. “Peptide Hormone ELABELA Promotes Rat Bone Marrow-Derived Mesenchymal Stem Cell Proliferation and Migration by Manipulating the Cell Cycle through the PI3K/AKT Pathway under the Hypoxia and Ischemia Microenvironment.” Stem Cell Research & Therapy 13 (1): 1–9. doi:10.1186/s13287-021-02691-1.